Finding 12264 (2022-003)

-
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-02-13
Audit: 16547
Organization: Epilepsy Foundation of America (MD)

AI Summary

  • Core Issue: Financial reports submitted did not match actual expenditures, leading to non-compliance.
  • Impacted Requirements: Accurate reporting of expenditures is mandated by the Uniform Guidance.
  • Recommended Follow-Up: Implement detailed review procedures for financial reports to ensure accuracy.

Finding Text

Finding 2022-003: Non-Compliance over Reporting - Reporting of Expenditures in Required Financial Reports Information on the Federal Program: Department of Human and Health - Center for Disease Control: Improving Epilepsy Programs, Services and Outcomes Through Partnerships, CFDA 93.850 Criteria: The Uniform Guidance requires organizations to submit required financial reports with accurate data pertaining to expenditures. Condition: The underlying expenditures support provided for the quarterly and annual Federal Financial Report (FFRs) did not tie to the expenditures reported. Cause: Due to a lack of effective review over required financial reports. Effect: Non-compliance with accuracy of amounts reported in required financial reports. Questioned Costs: There were no material questioned costs identified. Context: For all financial reports chosen for testing in 2022, which included two quarterly FFR and an annual FFR, the underlying expenditures support provided did not tie to the expenditures reported with a variance of $67,890. Repeat Finding: No. Recommendation: We recommend that management establish procedures to review and the financial reports in detail to ensure accuracy to underlying data.

Corrective Action Plan

Finding 2022-003: Non-Compliance over Reporting - Reporting of Expenditures in Required Financial Reports Information on the Federal Program: Department of Human and Health - Center for Disease Control: Improving Epilepsy Programs, Services and Outcomes Through Partnerships. Finding: The Uniform Guidance requires organizations to submit required financial reports with accurate data pertaining to expenditures. The underlying expenditures support provided for the quarterly and annual FFRs did not tie to the expenditures reported. Planned Corrective Action: Ensure all the transactions for the period (quarter) are accounted for including the cash and credit cards and also, that the period is closed immediately after the statements? preparation. Name and Person Responsible: : Caro Marie Brown (Senior Director of Finance) and Lindey Camerata (Controller). Anticipated Completion Date: March 31, 2023.

Categories

Reporting

Other Findings in this Audit

  • 12263 2022-002
    Material Weakness
  • 12265 2022-004
    Material Weakness
  • 12266 2022-005
    Material Weakness
  • 588705 2022-002
    Material Weakness
  • 588706 2022-003
    -
  • 588707 2022-004
    Material Weakness
  • 588708 2022-005
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.850 Improving Epilepsy Programs, Services, and Outcomes Through National Partnerships $3.80M